• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Effect of Coasting on Intracytoplasmic Sperm Injection Outcome in Antagonist and Agonist Cycle.滑行对拮抗剂方案和激动剂方案周期中卵胞浆内单精子注射结局的影响
Int J Fertil Steril. 2017 Apr-Jun;11(1):1-6. doi: 10.22074/ijfs.2016.5144. Epub 2016 Nov 11.
2
In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.促性腺激素释放激素(GnRH)激动剂方案与GnRH拮抗剂方案中取消周期后体外受精周期的结局
Fertil Steril. 2009 Feb;91(2):377-82. doi: 10.1016/j.fertnstert.2007.11.086. Epub 2008 Mar 5.
3
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.促性腺激素释放激素(GnRH)拮抗剂方案与GnRH激动剂方案中严重卵巢过度刺激综合征的风险:一项纳入1050个首次体外受精/卵胞浆内单精子注射周期的随机对照试验
Hum Reprod. 2016 Jun;31(6):1253-64. doi: 10.1093/humrep/dew051. Epub 2016 Apr 8.
4
The prevention of ovarian hyperstimulation syndrome.卵巢过度刺激综合征的预防
J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5.
5
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.在拮抗剂辅助生殖技术周期中,促性腺激素释放激素激动剂与绒毛膜促性腺激素用于触发排卵的比较。
Cochrane Database Syst Rev. 2010 Nov 10(11):CD008046. doi: 10.1002/14651858.CD008046.pub2.
6
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.在拮抗剂辅助生殖技术周期中,促性腺激素释放激素激动剂与绒毛膜促性腺激素用于触发卵母细胞的比较。
Cochrane Database Syst Rev. 2011 Jan 19(1):CD008046. doi: 10.1002/14651858.CD008046.pub3.
7
Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.通过停用促性腺激素和促性腺激素释放激素激动剂进行1至2天的短暂减药,可预防卵巢过度刺激综合征,且不影响治疗效果。
Fertil Steril. 2008 Dec;90(6):2172-8. doi: 10.1016/j.fertnstert.2007.10.033. Epub 2008 Apr 25.
8
Premature Progesterone Elevation Does Not Affect Pregnancy Outcome in High-Responder Patients Undergoing Short-Interval Coasting in IVF Cycles.在接受体外受精周期短间隔延缓治疗的高反应患者中,孕酮过早升高不影响妊娠结局。
Med Sci Monit Basic Res. 2015 Nov 30;21:247-52. doi: 10.12659/MSMBR.896244.
9
[Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].[多囊卵巢综合征女性在控制性卵巢刺激中,与长效促性腺激素释放激素激动剂方案相比,使用促性腺激素释放激素拮抗剂方案会增加早期妊娠丢失风险并降低活产率]
Tunis Med. 2009 Dec;87(12):834-42.
10
A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.对于有卵巢过度刺激综合征风险且正在接受控制性卵巢刺激的患者,采用促性腺激素释放激素激动剂触发排卵并积极进行黄体期支持。
Taiwan J Obstet Gynecol. 2015 Oct;54(5):583-7. doi: 10.1016/j.tjog.2015.08.012.

引用本文的文献

1
Risk factors, management, and future fertility of empty follicle syndrome: a retrospective study with real-world data.空卵泡综合征的风险因素、管理和未来生育能力:一项基于真实世界数据的回顾性研究。
Front Endocrinol (Lausanne). 2024 Jul 11;15:1424837. doi: 10.3389/fendo.2024.1424837. eCollection 2024.
2
Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention.卵泡抽吸术与延缓取卵用于预防卵巢过度刺激综合征
Saudi Med J. 2018 Mar;39(3):290-295. doi: 10.15537/smj.2018.3.22331.

本文引用的文献

1
Serum Oestradiol Pattern during Coasting is Different in Antagonist Cycles Compared with Long Agonist Cycles in In Vitro Fertilisation.在体外受精中,拮抗剂周期与长激动剂周期相比,激素替代周期中血清雌二醇模式不同。
Balkan Med J. 2013 Dec;30(4):406-9. doi: 10.5152/balkanmedj.2013.9028. Epub 2013 Dec 1.
2
Coasting, embryo development and outcomes of blastocyst transfer: a case-control study.滑行、胚胎发育与囊胚移植结局:一项病例对照研究
Reprod Biomed Online. 2014 Aug;29(2):231-8. doi: 10.1016/j.rbmo.2014.04.014. Epub 2014 May 15.
3
Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.预测和预防卵巢过度刺激综合征(OHSS):需要个体化而非标准化的治疗。
Reprod Biol Endocrinol. 2012 Apr 24;10:32. doi: 10.1186/1477-7827-10-32.
4
Agonist and antagonist coast.激动剂和拮抗剂海岸。
Fertil Steril. 2012 Mar;97(3):523-6. doi: 10.1016/j.fertnstert.2012.01.094. Epub 2012 Jan 20.
5
Withholding gonadotropins until human chorionic gonadotropin administration.推迟给予促性腺激素,直至人绒毛膜促性腺激素给药。
Semin Reprod Med. 2010 Nov;28(6):486-92. doi: 10.1055/s-0030-1265675. Epub 2010 Nov 16.
6
Preventing ovarian hyperstimulation syndrome: guidance for the clinician.预防卵巢过度刺激综合征:临床医生指南。
Fertil Steril. 2010 Jul;94(2):389-400. doi: 10.1016/j.fertnstert.2010.03.028. Epub 2010 Apr 22.
7
The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation.滑行时间和雌二醇下降对辅助生殖结局的影响:13 年预防卵巢过度刺激的 1068 个滑行周期经验。
Fertil Steril. 2010 Oct;94(5):1757-63. doi: 10.1016/j.fertnstert.2009.09.059. Epub 2009 Nov 25.
8
Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial.灵活使用促性腺激素释放激素(GnRH)拮抗剂与激发方案使用GnRH激动剂在体外受精治疗的低反应者中的比较:一项随机对照试验
Hum Reprod. 2008 Jun;23(6):1355-8. doi: 10.1093/humrep/den107. Epub 2008 Apr 10.
9
In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.促性腺激素释放激素(GnRH)激动剂方案与GnRH拮抗剂方案中取消周期后体外受精周期的结局
Fertil Steril. 2009 Feb;91(2):377-82. doi: 10.1016/j.fertnstert.2007.11.086. Epub 2008 Mar 5.
10
Are GnRH antagonists comparable to agonists for use in IVF?促性腺激素释放激素(GnRH)拮抗剂在体外受精(IVF)中的应用与激动剂相当吗?
Hum Reprod. 2007 Nov;22(11):2805-13. doi: 10.1093/humrep/dem270. Epub 2007 Sep 14.

滑行对拮抗剂方案和激动剂方案周期中卵胞浆内单精子注射结局的影响

The Effect of Coasting on Intracytoplasmic Sperm Injection Outcome in Antagonist and Agonist Cycle.

作者信息

İltemir Duvan Z Candan, Namlı Kalem Müberra, Onaran Yuksel, Aktepe Keskin Esra, Ayrım Aylin, Pekel Aslıhan, Kafalı Hasan, Turhan Nilgün

机构信息

Department of Obstetrics and Gynaecology, School of Medicine, Turgut Ozal University, Ankara, Turkey.

Department of IVF-Embriology, School of Medicine, Turgut Ozal University, Ankara, Turkey.

出版信息

Int J Fertil Steril. 2017 Apr-Jun;11(1):1-6. doi: 10.22074/ijfs.2016.5144. Epub 2016 Nov 11.

DOI:10.22074/ijfs.2016.5144
PMID:28367298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5215705/
Abstract

BACKGROUND

Coasting can reduce the ovarian hyperstimulation syndrome (OHSS) risk in ovulation induction cycles before intracytoplasmic sperm injection (ICSI). This study aimed to investigate the effect of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist protocols to controlled ovarian hyperstimulation (COH) cycles with coasting on the parameters of ICSI cycles and the outcome.

MATERIALS AND METHODS

In a retrospective cohort study, 117 ICSI cycles were per- formed and coasting was applied due to hyperresponse, between 2006 and 2011. The ICSI outcomes after coasting were then compared between the GnRH agonist group (n=91) and the GnRH antagonist group (n=26).

RESULTS

The duration of induction and the total consumption of gonadotropins were found to be similar. Estradiol (E) levels on human chorionic gonadotropin (hCG) day were found higher in the agonist group. Coasting days were similar when the two groups were compared. The number of mature oocytes and the fertilization rates were similar in both groups; however, the number of grade 1 (G1) embryos and the number of transferred embryos were higher in the agonist group. Implantation rates were significantly higher in the antagonist group compared to the agonist group. Pregnancy rates/embryo transfer rates were higher in the antagonist group; however, this difference was not statistically significant (32.8% for agonist group vs. 39.1% for antagonist group, P>0.05).

CONCLUSION

The present study showed that applying GnRH-agonist and GnRH-antago- nist protocols to coasted cycles did not result in any differences in cycle parameters and clinical pregnancy rates.

摘要

背景

在卵胞浆内单精子注射(ICSI)前的促排卵周期中,“降调节”可降低卵巢过度刺激综合征(OHSS)的风险。本研究旨在探讨促性腺激素释放激素(GnRH)激动剂方案和GnRH拮抗剂方案应用于“降调节”的控制性卵巢刺激(COH)周期对ICSI周期参数及结局的影响。

材料与方法

在一项回顾性队列研究中,2006年至2011年间共进行了117个ICSI周期,因卵巢反应过度而采用“降调节”。然后比较GnRH激动剂组(n = 91)和GnRH拮抗剂组(n = 26)“降调节”后的ICSI结局。

结果

诱导时间和促性腺激素的总用量相似。人绒毛膜促性腺激素(hCG)日的雌二醇(E)水平在激动剂组中较高。两组比较时,“降调节”天数相似。两组成熟卵母细胞数量和受精率相似;然而,1级(G1)胚胎数量和移植胚胎数量在激动剂组中较高。拮抗剂组的着床率显著高于激动剂组。拮抗剂组的妊娠率/胚胎移植率较高;然而,这种差异无统计学意义(激动剂组为32.8%,拮抗剂组为39.1%,P>0.05)。

结论

本研究表明,在“降调节”周期中应用GnRH激动剂方案和GnRH拮抗剂方案在周期参数和临床妊娠率方面未产生任何差异。